The Daily Hit: July 25, 2023

The Daily Hit is a recap of the top financial news stories for July 25, 2023.

On the Site

Maryland Hemp Companies Sue State Over Adult-Use Marijuana Rules

A group of hemp companies in Maryland have filed suit against the governor and several state officials, claiming that the regulatory plan lawmakers authorized for the recreational cannabis industry will put them out of business. Read more here.

Hemp Hearing on FDA Inaction to Be Held Thursday

The Subcommittee on Health Care and Financial Services will host a hearing to look at the Food and Drug Administration’s failure to regulate hemp-derived and cannabidiol products under existing authorities for years. Read more here.

Aleafia Health Files for Creditor Protection After Investors Axe RWB Deal

Toronto-based Aleafia Health Inc. (TSX: AH) (OTCQB: ALEAF) filed for creditor protection under the CCAA – akin to bankruptcy proceedings in the U.S. – in response to recent financial struggles, complicated by a cancelled acquisition proposal by Red White & Bloom Brands Inc. (CSE: RWB) (OTC: RWBYF), which was officially sacked on July 14, a month after the deal was announced. Read more here.

Parallel, IIP Duel Over Insolvency Claims in $6M Dispute

Atlanta-based multistate operator Parallel’s subsidiary, Goodblend Pennsylvania LLC, is attempting to avoid a near $6 million payment relating to a failed grow facility by declaring insolvency, according to a recent complaint filed in a Pennsylvania court. Read more here.

Detroit to Open 2nd Wave of Recreational Cannabis Licenses

The city of Detroit on Monday said it will start accepting applications for limited marijuana business licenses on August 1. These licenses will include dispensaries, microbusinesses, and consumption lounges. Read more here.

In Other News

Flora Growth

Flora Growth Corp. (Nasdaq: FLGC) will sell its Colombian-related subsidiaries and assets to a private company for C$800,000. The sale is expected to close by July 31. The company intends to maintain a presence in Latin America through Just Brands’ distribution relationships. Read more here.

MIRA Pharmaceuticals

Baltimore-based MIRA Pharmaceuticals filed a registration statement with the U.S. Securities and Exchange Commission announcing its plan to go public on the Nasdaq under the symbol MIRA. The proceeds from the initial public offering will fund the clinical studies necessary for MIRA’s synthetic cannabis drug to receive approval from the Food and Drug Administration, the filing said. Read more here.


The Missouri Department of Health and Senior Services will begin accepting cannabis microbusiness applications on Thursday, July 27. The application window will be open through Aug. 10. Applications can be submitted through the online portal. The lottery to select winners will take place no later than Sept. 1. Read more here.

Leave a Reply

Your email address will not be published. Required fields are marked *

Get the latest cannabis news delivered right to your inbox

The Morning Rise

Unpack the industry with the daily cannabis newsletter for business leaders.

 Sign up

About Us

The Green Market Report focuses on the financial news of the rapidly growing cannabis industry. Our target approach filters out the daily noise and does a deep dive into the financial, business and economic side of the cannabis industry. Our team is cultivating the industry’s critical news into one source and providing open source insights and data analysis


Recent Tweets

Get the latest cannabis news delivered right to your inbox

The Morning Rise

Unpack the industry with the daily cannabis newsletter for business leaders.